Back to search
FDAFDA · Food and drugs·Recall number D-0411-2019

Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 30 count - NDC 43547-331-03

Published February 6, 2019 · Recall initiated: January 18, 2019

Summary

FDA records drug Class II recall D-0411-2019, published February 6, 2019 and initiated January 18, 2019. Recalling firm: Prinston Pharmaceutical Inc; Status: Completed; Reported quantity: 32692 bottles; Lot: 327A18001 327A18002. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What to do

Voluntary: Firm initiated · Letter

Get an email if IRBESARTAN AND HYDROCHLOROTHIAZIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
IRBESARTAN AND HYDROCHLOROTHIAZIDE
Manufacturer
Prinston Pharmaceutical Inc
Distributor
Nationwide
UPC
0343547331030
Lot
327A18001 327A18002
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 30 count - NDC 43547-331-03 recalled?

Yes. FDA published recall D-0411-2019 on February 6, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: IRBESARTAN AND HYDROCHLOROTHIAZIDE. UPC: 0343547331030.